Medtronic continues assembly of industry’s “broadest” pain therapy portfolio
Medtronic formally launched ViaVerte at ASPN 2026, with its $650m acquisition of SPR Therapeutics completing at the meeting’s outset on 16 July.
27 July 2026
27 July 2026
Medtronic formally launched ViaVerte at ASPN 2026, with its $650m acquisition of SPR Therapeutics completing at the meeting’s outset on 16 July.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.